An ear-based approach to neuromodulation
V-Link delivers transauricular vagus nerve stimulation without an implant. The programme begins with subarachnoid hemorrhage and neurocritical care, where secondary inflammation can worsen injury after the original event.
Preparing for pivotal studies
Capital funds final device development, verification and validation testing, and FDA submissions. Breakthrough device designation supports the development pathway; pivotal-trial preparation remains the next step.
Where the funding goes
- Final device development
- Verification and validation testing
- FDA submissions and pivotal-trial preparation